FIELD: chemistry.
SUBSTANCE: invention relates to use of (3,5-di-tert-butyl-4-hydroxyphenylthiolate)triphenyltin as an agent for inhibiting metastasis of Lewis epidermoid carcinoma in the lungs.
EFFECT: antimetastatic agent suitable for intraperitoneal administration.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR INHIBITING METASTASIS IN THE LUNGS | 2021 |
|
RU2762730C1 |
| METHOD OF COMBINATION THERAPY OF B16 MELANOMA IN METRONOMIC MODE IN EXPERIMENT | 2022 |
|
RU2792561C1 |
| MEANS FOR INHIBITION OF METASTASIS IN LUNGS | 2016 |
|
RU2632703C1 |
| AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
| DRUG WITH ANTIPROLIFERATIVE AND ANTIMETASTATIC EFFECTS AGAINST LEWIS LUNG CARCINOMA WHEN INJECTED INTRAPERITONEALLY | 2022 |
|
RU2792144C1 |
| METHOD FOR ACHIEVING ANTIMETASTATIC EFFECT IN EXPERIMENT | 2017 |
|
RU2661704C1 |
| NEW STERICALLY HINDERED PHENOLS CONTAINING BENZOFUROXAN FRAGMENTS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2796810C1 |
| ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
| 2-AMINOCHROMEN DERIVATIVES EXHIBITING ANTI-TUMOR ACTIVITY; PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2704262C1 |
| ANTIMETASTATIC COMPOSITION | 2006 |
|
RU2308966C1 |
